Evidence map›Paper›PMID 24011425›Full record

ArticleEuropean urology2014

Molecular characterization of prostate cancer following androgen deprivation: the devil in the details.

Christopher E Barbieri, Mark A Rubin

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in European urology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  2. SOX4: The unappreciated oncogene.Seminars in cancer biology · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Christopher E BarbieriDepartment of Urology, Weill Medical College of Cornell University, New York, NY, USA; Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY, USA. Electronic address: chb9074@med.cornell.edu.
Mark A RubinDepartment of Urology, Weill Medical College of Cornell University, New York, NY, USA; Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY, USA; Institute for Precision Medicine of Weill Medical College and New York-Presbyterian Hospital, New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expressionbeta CateninHumansMaleProstatic Neoplasms, Castration-ResistantRNA, NeoplasmWnt Signaling Pathwaybeta CateninRNA, Neoplasm

Identifiers

PMID24011425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.